Stockscreener 앱 받기
1.96
2.62%
0.05
시간 외 거래:
1.95
-0.01
-0.51%
전일 마감가:
$1.91
열려 있는:
$1.93
하루 거래량:
3.30M
Relative Volume:
0.72
시가총액:
$84.84M
수익:
-
순이익/손실:
$-51.50M
주가수익비율:
-0.49
EPS:
-4
순현금흐름:
$-47.10M
1주 성능:
+53.12%
1개월 성능:
+49.62%
6개월 성능:
+11.36%
1년 성능:
-62.52%
1일 변동 폭
$1.84
$1.99
1주일 범위
$1.36
$2.01
52주 변동 폭
$0.79
$5.44
아웃룩 테라퓨틱스 Stock (OTLK) Company Profile
명칭
Outlook Therapeutics Inc
전화
(609) 619-3990
주소
111 S. WOOD AVENUE, ISELIN, NJ
OTLK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OTLK
Outlook Therapeutics Inc
|
1.96 | 84.84M | 0 | -51.50M | -47.10M | -4.00 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
ONC
Beone Medicines Ltd Adr
|
353.79 | 40.27B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
아웃룩 테라퓨틱스 Stock (OTLK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-08-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-03-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-02-15 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2024-01-25 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-12-27 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-08-31 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-08-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-08-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-08-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-08-30 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-08-30 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-07-13 | 개시 | CapitalOne | Overweight |
| 2023-04-03 | 개시 | Guggenheim | Buy |
| 2023-02-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-10-31 | 개시 | BTIG Research | Buy |
| 2022-09-13 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-11 | 개시 | Ladenburg Thalmann | Buy |
| 2019-05-16 | 개시 | Oppenheimer | Outperform |
| 2019-04-22 | 개시 | Ascendiant Capital Markets | Buy |
모두보기
아웃룩 테라퓨틱스 주식(OTLK)의 최신 뉴스
Why Outlook Therapeutics Inc. stock is a must watch in 2025Earnings Summary Report & Safe Capital Growth Stock Tips - newser.com
What analyst consensus implies for Outlook Therapeutics Inc. (41O) stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Will Outlook Therapeutics Inc. (41ON) stock enhance shareholder valueJobs Report & Verified Momentum Stock Ideas - newser.com
How Outlook Therapeutics Inc. stock reacts to Fed rate cutsWeekly Market Report & Technical Pattern Based Signals - newser.com
Will Outlook Therapeutics Inc. (41O) stock beat value stocksMarket Movers & Accurate Buy Signal Notifications - newser.com
Outlook Therapeutics Shares Surge on Key FDA Regulatory Milestone - Ad-hoc-news.de
Is Outlook Therapeutics Inc. stock a smart buy before Fed meetingMarket Risk Analysis & Fast Moving Trade Plans - newser.com
How Outlook Therapeutics Inc. (41O) stock trades under stagflationWeekly Trade Review & Trade Opportunity Analysis Reports - newser.com
Is Outlook Therapeutics Inc. (41ON) stock expanding market penetrationGold Moves & Real-Time Price Movement Reports - newser.com
Is Outlook Therapeutics Inc. (41ON) stock worth buying before Fed actionJuly 2025 Levels & Accurate Intraday Trading Signals - newser.com
Is Outlook Therapeutics Inc. stock a dividend growth opportunity2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Is Outlook Therapeutics Inc. (41ON) stock cheap vs fundamentals2025 Market Overview & Weekly Market Pulse Updates - newser.com
Outlook Therapeutics Inc. stock momentum explainedEarnings Recap Report & Smart Money Movement Tracker - newser.com
Outlook Therapeutics Inc. (OTLK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Outlook Therapeutics Surges as FDA Greenlights ONS-5010 Resubmission - timothysykes.com
What technical models suggest about Outlook Therapeutics Inc.’s comeback - newser.com
How to interpret RSI for Outlook Therapeutics Inc. stockPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Is Outlook Therapeutics Inc. stock cheap at current valuationTrend Reversal & Daily Volume Surge Signals - newser.com
FDA Acceptance Boosts Outlook Therapeutics Shares Significantly - timothysykes.com
Biotech Investor Alert: Outlook Therapeutics Nears Critical FDA Verdict - AD HOC NEWS
H.C. Wainwright Sticks to Its Hold Rating for Outlook Therapeutics (OTLK) - The Globe and Mail
FDA Accepts Outlook Therapeutics’ Resubmission for Eye Drug, Stock Surges - StocksToTrade
FDA Accepts Outlook Therapeutics’ BLA Resubmission for ONS-5010 - timothysykes.com
아웃룩 테라퓨틱스 (OTLK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
0.82%
자본화:
|
볼륨(24시간):